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Abstract
The usefulness of spa typing was evaluated in relation to pulsed-field gel electrophoresis (PFGE), as a tool for epidemiological typing of
methicillin-resistant Staphylococcus aureus (MRSA) in a low-prevalence region in southern Sweden. Bacterial isolates from 216 MRSA
cases, newly identified in 2000–2004, were studied. The isolates were obtained from infected patients (31%), and from colonized individ-
uals found by screening (69%). In total, 49 spa types and 73 PFGE patterns were identified. The discriminatory power of spa typing was
lower (94.9 ± 1.8%) than that of PFGE (97.3 ± 1.2%). For two spa types (t002 and t008) the Panton–Valentine leukocidin results added
useful discriminatory information. The most common spa types were t044 (n = 31; four PFGE patterns), t002 (n = 24; 10 PFGE
patterns), t067 (n = 12; four PFGE patterns), t050 (n = 12; one PFGE pattern), and t324 (n = 11; one PFGE pattern). Epidemiological
investigations identified 91 single cases and 39 transmission chains, each involving two to 13 cases. All the transmission chains were held
together both by spa and PFGE typing. Among the 91 single-case isolates, 33 spa types and 50 PFGE patterns were unique (matchless)
at the time of identification. The low prevalence of MRSA, the low number of outbreaks, and the wide spectrum of strains due to fre-
quent acquisitions abroad (49% of the cases), makes spa typing a useful complement to epidemiological investigations in our setting.
However, we still recommend the continued use of PFGE for further discrimination of isolates with identical spa types when epidemio-
logical data can not exclude possible transmission.
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Introduction
The increasing prevalence of methicillin-resistant Staphylococ-
cus aureus (MRSA) is a cause for concern in many countries.
In 2004, MRSA accounted for 25–50% of S. aureus septicae-
mia cases in southern Europe (EARSS; http://www.rivm.nl/
earss). Although the MRSA rate is low in Sweden, the num-
ber of cases reported has been increasing each year (http://
www.smittskyddsinstitutet.se/) [1]. Since 2000 MRSA has
been notifiable in Sweden, both from infection and coloniza-
tion. The Swedish Institute for Infectious Disease Control
(SMI) continually surveys the prevalence and geographical
spread of MRSA, and isolates from every newly reported
case are referred to SMI for epidemiological typing.
Pulsed-field gel electrophoresis (PFGE) of macro restric-
tion fragments is a commonly used technique for epidemio-
logical typing of many bacterial species. Analysis of
SmaI-digested DNA is still considered to be the reference
standard for typing MRSA, and the method has proven supe-
rior to most other typing methods [2,3]. It was the first
molecular typing method for which guidelines for interpreta-
tion of data were suggested [4]. Even though the effects of
such standardization have been far-reaching, low interlabora-
tory comparability is still a problem [5].
Sequence-based typing methods such as multilocus
sequence typing (MLST) [6], and spa typing, sequencing of
the polymorphic X-region of the S. aureus protein A gene
[7–9], have become frequently used alternatives to PFGE.
This is due to the portability of sequence data and ease of
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exchanging results via databases available on the internet
(http://www.mlst.net and http://www.spaserver.ridom.de).
However, MLST, which relies on sequence analysis of frag-
ments of seven housekeeping genes, is best suited for study-
ing the evolutionary history of S. aureus [10,11]. The single
locus analysis performed in spa typing gives information that
has proven adequate in hospital settings [9,12,13].
The usefulness of spa typing, in comparison with PFGE,
for early detection of transmission has, to our knowledge, so
far not been evaluated in a low-prevalence region. In this
study, we included all MRSA consecutively referred to the
department of Clinical Microbiology and Immunology (CMI),
Lund University Hospital, Sweden, during 2000–2004.
Detailed epidemiological information, collected by the local
infection control units, formed the basis of our evaluation.
All isolates were further characterized by the presence or
absence of genes coding for Panton–Valentine leukocidin
(PVL). Representative isolates were subjected to MLST.
Materials and Methods
Bacterial isolates
A total of 216 MRSA isolates were analysed, each represent-
ing a case detected through clinical or screening samples
referred to CMI from 2000 to 2004. The isolates were iden-
tified as MRSA by an in-house conventional PCR using the
primers nuc N1-f (5¢-GCGATTGATGGTGATACGGTT-3¢),
and nuc N2-r (5¢-CAAGCCTTGACGAACTAAAGC-3¢),
adapted from Brakstad et al. [14], and mecA P3-f (5¢-GGTA
CTGCTATCCACCCTCAA-3¢) and mecA P4-r (5¢-CTTACT
GCCTAATTCGAGTGCTA-3¢). Staphylococcus aureus CCUG
35601 served as positive control for the nuc/mecA PCR and
S. aureus ATCC 49775 for the lukS-PV/lukF-PV PCR.
Epidemiological investigations
CMI serves a region of c. 700 000 inhabitants. MRSA cases
were categorized as either ‘Infected’ (cases with clinical
infection) or ‘Colonized’ (cases found through screening).
Cases that had recently (defined here as within the preced-
ing 6 months) been employed or treated in a hospital or
nursing home were defined as ‘Healthcare related’. Cases
with no such contacts were defined either as ‘Community
related’ or ‘Unknown’ when a hospital connection could not
be excluded. Recent immigration, or travel to a foreign
country, was defined as ‘Acquired abroad’.
Screening samples were routinely taken from (i) patients
and medical staff who had recently been employed or trea-
ted in a hospital or nursing home outside Scandinavia, or in
a hospital or nursing home in Scandinavia known to have
MRSA patients, (ii) fellow patients and staff at the same
ward(s) as healthcare-related MRSA cases, and (iii) house-
hold members of community-related cases. Samples were
taken from the anterior nares, throat, perineum, skin lesions,
intravenous and stoma sites and urine from catheterized
patients. Newly discovered MRSA cases were diagnosed at
or referred to the Departments of Infectious Diseases at
Lund University Hospital, Kristianstad Central Hospital,
or Helsingborg Hospital. Epidemiological investigations
were performed in collaboration with the Hospital Infection
Control Units.
spa Typing
spa Typing was performed at CMI, as described elsewhere
[9], using the primers SPA1-f 5¢-AAGACGATCCTTCGGT
GA-3¢ (adapted from [8]), and SPA2-r 5¢-CACCAGGTTTAA
CGACAT-3¢ [7]. In 2004, SPA2-r was substituted by SPA3r
5¢-AGCAGTAGTGCCGTTTGC-3¢ (in-house). SPA-F9-f
5¢-AACGTAACGGCTTCATCC-3¢ was introduced when
insufficient PCR product was obtained from spa type t355
isolates. These primers correspond to nucleotides 1094–
1111, 1492–1475, 1533–1516 and 1067–1084, respectively,
of S. aureus NCTC 8325-4 (GenBank J01786). All sequencing
reactions were carried out using the ABI PRISM BigDye ter-
minator cycle sequencing ready reaction kit (Applied Biosys-
tems, Foster City, CA, USA). The RIDOM STAPHTYPE software
(Ridom GmbH, Wu¨rzburg, Germany) was used for sequence
analysis and assignment of spa types [9].
PFGE
PFGE analysis was performed at SMI according to standard
procedures [15]. Briefly, SmaI-digested DNA was electro-
phoresed in 1% agarose in 0.5· TBE at 14C for 23 h, using
the CHEF Mapper XA system (Bio-Rad Laboratories, Hercu-
les, CA, USA) set at 6 V/cm, with pulse times linearly
increased from 5 s initial switch time to 60 s final switch
time. SmaI-digested DNA from S. aureus NCTC 8325 was
included as normalization standard on every gel. Ethidium
bromide-stained gels were photographed over UV light with
a charge-coupled device camera. The DNA banding patterns
were included in a national MRSA–PFGE database, using the
BIONUMERICS software, version 4.61 (Applied Maths NV, Sint-
Martens-Latem, Belgium). Pair-wise similarities were calcu-
lated using the Dice coefficient, and the algorithm UPGMA
(Unweighted Pair Group Method using Arithmetic averages)
was used for constructing dendrograms. Position tolerance
and optimization were both set at 1%. Each distinguishable
banding pattern, within the size range 48–679 kb, was
assigned a PFGE pattern name as in the following examples:
(i) Bel EC-3a, UK E15, UK E16 (patterns indistinguishable
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from DNA banding patterns of MRSA in the HARMONY
collection [5]), (ii) SE03-5, SE03-5b (patterns not seen in the
HARMONY collection, but in two or more MRSA isolates in
the national collection; SE = Sweden, 03 = 2003, the year
when MRSA with this PFGE pattern was first isolated in
Sweden, 5 = a serial number for each unrelated SE03
pattern, b = an alphabetical suffix added to denote close
relationship (>80% pair-wise Dice similarity) to SE03-5 or
SE03-5a), (iii) Unique 001, Unique 002, etc. (patterns unre-
lated to any other pattern within the database).
MLST
MLST was performed, as previously described [6], on MRSA
isolates representative of each SE prototype PFGE pattern.
Sequence types (STs) were determined using the MLST data-
base (http://www.mlst.net).
PVL genes
The PVL genes lukS-PV and lukF-PV were detected by PCR as
described [16].
Statistical analysis
The discriminatory capacities of spa typing and PFGE were
measured with Simpson’s index of diversity [17] with 95% CI
as previously described [18]. Concordance between the
two methods was calculated as described elsewhere [19]. All
calculations were performed using all single-case isolates
(n = 91) and the first isolate in each epidemiologically defined
transmission chain (n = 39). Chi-square test was used for
comparison of proportions.
Results and discussion
The number of new cases, identified at CMI, increased each
year, from 11 in 2000 to 81 in 2004, corresponding to an
increase in incidence of c. 2–12 new cases per 100 000
inhabitants per year. This low incidence allowed for the
implementation of an extensive infection control programme
including early case-finding through extensive screening of
patients with risk factors, and contact tracing combined with
infection control measures such as isolation of MRSA cases.
Generous inclusion of people in the community seeking
medical care made culturing from this group feasible, and
allowed early identification of new cases [1]. This may
explain why a minority (66/216; 31%) of the isolates in this
study were from infected cases. Skin and soft tissue infec-
tions dominated (53/66; 80%), followed by urinary tract
infections and respiratory tract infections (6/66; 9% each).
Only one isolate was obtained from a blood culture. The
epidemiological investigations identified 105 (49%) cases as
community related and 96 (44%) as healthcare related. The
origin of acquisition could not be established for 15 (7%)
cases, 12 of whom were immigrants who had recently visited
their countries of origin. Infected cases were more fre-
quently community related (44/66; 67%) than healthcare
related (15/66; 23%), whereas colonized cases were more
often healthcare related (81/150; 54%) than community
related (61/150; 41%). The proportion of infected cases was
significantly higher among community-related than health-
care-related cases, 42% vs. 16% (p <0.001). Half of the cases
(107/216; 49%) had acquired their MRSA abroad, from a
wide range of countries (Fig. 1).
Among the 216 MRSA isolates, we identified 49 spa types
and 72 PFGE patterns (Fig. 1). One of the PFGE patterns,
SE97-4, was represented by two DNA banding patterns dif-
fering in the high molecular weight part of the gel but indis-
tinguishable within the normalized part of the gel. The
concordance between spa and PFGE typing was 96% (both
when using 72 and 73 PFGE patterns in the calculation),
which is in agreement with other reports [20,21].
In total, 88 spa type/PFGE pattern combinations were
recorded. t044/SE94-1 (ST80) was the most common combi-
nation (n = 27). t044 was also seen in combination with
SE94-1b (n = 2), SE94-1d (n = 1) and SE94-1m (n = 1). A
similar situation, with different PFGE patterns among t044
FIG. 1. Characteristics of 216 MRSA isolated from infected or colonized cases in a low-prevalence region in Sweden 2000–2004. An Unweighted
Pair Group Method using Arithmetic averages (UPGMA) dendrogram shows the relatedness between the 72 pulsed-field gel electrophoresis
patterns seen among the isolates. The scale shows percent similarity. a: (S), single case; (#n), transmission chain number. b: Country of acquisi-
tion when not Sweden: AF, Afghanistan; AU, Australia; BA, Bosnia-Herzegovina; CL, Chile; CO, Colombia; DE, Germany, EG, Egypt; ES, Spain;
ET, Ethiopia; FR, France; FRY, Federal Republic of Yugoslavia until February 2003, thereafter Serbia-Montenegro; GM, Gambia; GR, Greece; HR,
Croatia; HU, Hungary; IN, India; IQ, Iraq; IR, Iran; IT, Italy; KOR, Korea; LK, Sri Lanka; LV, Latvia; MT, Malta; PA, Panama; PH, the Philippines;
PL, Poland; PRC, People’s Republic of China; RU, Russia; SA, Saudi-Arabia; SO, Somalia; SY, Syria; TN, Tunisia; TT, Trinidad and Tobago; UAE,
United Arab Emirates; UK, United Kingdom; USA, United States of America. c: 2 (#4); 2 (S), 5 (#5), 2 (#6), 2 (#7). d: 6 (S), 2 (#13), 2 (#14), 2
(#15), 2 (#16). e: DE, ES, FR, GR, HU, TT. f: 2 (S), 2 (#17), 2 (#18); 1 (S); 12 (#19); 2 (#20); 1 (S). g: 1 (S); 7 (S), 3 (#22), 3 (#23), 3 (#24), 1
(#25), 2 (#26), 3 (#27), 3 (#28), 2 (#29). h: FRY, IQ, MT, SA, SY, TN, UAE.
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isolates, has been described in a Danish report [22]. SE94-1
was also described in combination with t042 (n = 1) and
t131 (n = 4), which are both closely related to t044. All
t044, t042 and t131 isolates were PVL-positive. ST80/t044
PVL-positive MRSA is widely spread, and often community
acquired in Europe [22–26]. The majority of our t044/SE94-1
PFGE pattern spa  type MLST PVL No. of cases a Country b
NCTC 8325
SE01-24 t037 nd – 1 (S N
SE03-5  t008 ST8 + 2 (S), 4 (#1) USA
SE03-5b t008 ST8 + 1 (S)
SE00-11 t008 ST8 – 2 (S U
SE01-23 t311 ST5 + 1 (S M
SE97-9a t037 ST241 – 2 (S R
SE97-9b t297 ST241 – 1 (S U
SE99-6 t037 ST239 – 1 (S R
Unique 242 t037 nd – 1 (S U
Unique 363 t037 nd – 1 (S G
SE98-5a t425 ST239 – 1 (S V
SE97-1f t030 ST239 – 1 (#2) HR
SE97-1g t030 ST239 – 1 (S), 1 (#2) FRY, HR
SE01-15 t030 ST444 – 2 (S RY
SE04-2 t174 ST1 – 6 (#3)
SE98-3 t148;  t324 ST72 – 13 c KOR
SE04-1 t091 nd – 4 (#8) AF
Unique 065 t001 nd – 1 (S T
SE98-8 t041 ST228 – 1 (S A
SE98-8d t041 ST228 – 1 (S U
SE98-8c t041 ST228 – 1 (S T
SE98-8h t001 ST228 – 1 (S R
SE01-5 t002;  t509 ST149 – 1 (S); 2 (#9)
SE01-5b t002 ST149 – 1 (S)
SE00-9c t067 ST125 – 9 (#10) ES
Unique 290    t539 nd – 1 (S)
Unique 093 t067 nd – 1 (S
) I
) R
) G
) I
) A
) I
) R
) E
) L
) F
) I
) B
) H
) I
) H
) ES
SE02-1 t002;  t010;  t312 ST5 – 1 (S); 2 (#11);  2 (#12)
SE99-7a t067 nd – 1 (S S
SE02-16 t002 ST5 – 1 (S S
Bel EC-3a t002 ST5 + 1 (S K
SE02-21 t002 ST5 – 2 (S H
SE99-1 t002 ST5 – 14 d e
SE99-1b t002 ST5 – 1 (#16 R
Unique 092 t067 nd – 1 (S R
Unique 249 t002 nd – 1 (S)
Unique 185 t002 nd – 1 (S K
Unique 212 t003 nd – 1 (S E
SE02-15 t286 ST1 – 3 (S OR
SE02-15a t286 ST1 – 1 (S OR
SE02-15b t286 ST1 – 2 (S OR
SE02-18 t127 ST1 + 1 (S SA
Unique 118 t380 nd + 1 (S)
SE97-3 t015;  t065;  t133;  t230 ST45 – 3 (S); 1 (S);  1 (S);  1 (S) FRY, GR, PL
SE97-3aa t015 ST45 – 1 (S)
SE97-3f t015;  t026;  t050;  t295;  t390 ST45 – 22 f FRY
SE97-3g t361 ST45 – 1 (S RY
SE97-3z t230 ST45 – 1 (S RY
SE97-3aq t026 ST45 – 1 (#19)
SE98-6 t032 ST22 – 1 (S)
SE98-6i t032 ST22 – 1 (S K
SE98-6a t032 ST22 – 1 (S K
UK E15 t032 ST22 – 2 (#21
) E
) E
) L
) P
) F
) F
) U
) D
) K
) K
) K
) U
) F
) F
) U
) U
) UK
SE94-1 t042;  t044 ST80 + 28 g h
SE94-1b t044;  t131 ST80 + 2 (#25);  4 (#30) SO
SE94-1d t044 ST80 + 1 (S)
SE94-1m t044 ST80 + 1 (S Y
Unique 099 t296 nd – 1 (S T
SE00-3 t019;  t122 ST30 + 1 (S), 2 (#31);  1 (S) USA, PH
SE00-3d t019 ST30 + 3 (#32 H
SE00-3c t313 ST30 + 1 (S RC
SE00-3e t019 ST30 + 3 (#33)
SE97-4 t018;  t323 ST30 – 2 (#34);  3 (#35)
SE97-4 t253 ST30 – 4 (#36)
SE97-4f t374 ST30 – 2 (#37)
Unique 404 t381 nd – 1 (S R
UK E16 t018 ST36 – 1 (S K
SE01-7a t437 ST59 + 1 (S L
SE98-1e t216 ST59 – 4 (#38 A
SE01-3 t355 ST152 + 1 (S), 4 (#39 RY
SE01-3a t355 ST152 + 2 (S RY
SE01-9 t149 ST5 – 2 (S L, CO
SE04-9 t421 nd – 1 (S
) S
) E
) P
) P
) G
) U
) P
) P
) F
) F
) C
) ET
lambda
100806040
CMI Petersson et al. spa Typing for MRSA surveillance 459
ª2009 The Authors
Journal Compilation ª2009 European Society of Clinical Microbiology and Infectious Diseases, CMI, 16, 456–462
isolates were found in families with connection to the Middle
East, and nearly all of the imported cases were from coun-
tries around the Persian Gulf.
t002/SE99-1 (ST5) was the second most common combi-
nation (n = 14). t002 was seen in another ten isolates show-
ing nine different PFGE patterns that clustered with SE99-1
at 67% similarity in the UPGMA dendrogram. In total, 11 spa
types and 23 PFGE patterns were recorded among 51 iso-
lates belonging to MLST clonal complex 5 (CC5; here STs 5,
125, 149 and 228). This great variation was not surprising
considering the evolution and worldwide spread of MRSA
belonging to CC5 [10,11]. All but two of the isolates belong-
ing to CC5 were PVL-negative. The two PVL-positive isolates
were from cases with a history of recent travel to Asia
(t002/Bel EC-3a) and Africa (t311/SE01-23).
The third most common combination (n = 12) was t050/
SE97-3f (ST45). Twenty isolates had spa types (n = 8) and
PFGE patterns (n = 5) closely related to t050 and SE97-3f,
respectively. A majority of cases with ST45 isolates (24/32)
had acquired their MRSA in Sweden, and none of them had
connections with countries outside Europe. ST45 MRSA iso-
lates have frequently been reported from many European
countries [20–22,27]. All ST45 isolates were PVL-negative.
Also common during the study period were PVL-negative
ST72 MRSA with PFGE pattern SE98-3, in combination with
either spa type t324 (n = 11) or t148 (n = 2). These isolates
were from children adopted from Korea, and from members
of their Swedish families. In total, four transmission chains,
no. 4 (2 cases), no. 5 (5 cases), no. 6 (2 cases) and no. 7 (2
cases), involved ST72 MRSA.
PVL genes were detected in 13/49 spa types and 17/72
PFGE patterns. In total, 31% of the isolates (25% of the sin-
gle-case isolates and 38% of the transmission-chain isolates)
were PVL-positive. Isolates with the same PFGE pattern
were either all PVL-positive or all PVL-negative. The same
homogeneity was seen for all spa types except t002 and
t008, for which the PVL results added useful discriminating
information. The PVL-positive MRSA variants found in our
material have been reported from countries around the
world [23,26–28]. The PVL-positive t008/SE03-5 (ST8; n = 7)
MRSA was identified as a variant of USA300 [Hæggman,
et al. 47th Intersci Conf Antimicrob Agents Chemother,
abstract C2-143], the predominant community-associated
MRSA in the USA [28].
Epidemiological investigations identified 39 transmission
chains, involving two to 13 cases, and 91 single cases (Table 1
and Fig. 1). Twenty-three PFGE patterns and 25 spa types
were identified among the 39 transmission chains. Twenty-
eight of the 36 small chains (two to five persons) involved
transmission within families only. Most of these family
members (85/97) had had no known recent contact with the
healthcare system. The remaining eight small chains (no. 11:
t010/SE02-1, no. 12: t312/SE02-1, no. 14: t002/SE99-1, no. 15:
t002/SE99-1, no. 20: t295/SE97-3f, no. 21: t032/UK E15, no.
25: t044/SE94-1, -1b, and no. 28: t044/SE94-1) involved one or
more healthcare-related cases, and in five of them (nos 12, 20,
21, 25 and 28) the index case had a clinical infection. The three
larger chains all involved healthcare-related cases. Chain no. 3
(t174/SE04-2, ST1) involved two patients and four personnel
in a nursing home. Chain no. 10 (t067/SE00-9c, ST125)
involved seven patients and two personnel in a hospital ward.
The index patient in this chain had recently been hospitalized
in Spain, where ST125 MRSA was already prevalent at that
time [29]. The largest chain (no. 19) involved five patients and
five members of the personnel in a nursing home, and three
relatives of the personnel. Twelve of the isolates had PFGE
pattern SE97-3f (ST45) and spa type t050 (repeat pattern 08-
16-02-16-34-34-17-34-16-34), and one isolate, obtained from
one of the relatives, differed slightly both by PFGE (SE97-3aq)
and spa typing (t026, repeat pattern 08-16-34). This was the
TABLE 1. Concordance between epi-
demiological data and typing results
for 125 MRSA isolates involved in 39
epidemiologically defined transmis-
sion chains
No. of cases
per
transmission
chain
No. of
transmission
chains
No. of
spa types
No. of
PFGE
patterns
No. of transmission
chains comprising
only isolates
indistinguishable by
spa
Typing PFGE
2 19 14 12 19 18a
3 10 4 7 10 8a
4 6 6 6 6 6
5 1 1 1 1 1
6 1 1 1 1 1
9 1 1 1 1 1
13 1 2b 2b 0b 0b
aThe three deviant transmission chains were chain nos 2, 16 and 25, all three comprising closely/possibly
related PFGE patterns (Fig. 1).
bOne isolate, given the same classification with both typing methods, differed slightly from the other twelve
isolates in this transmission chain (no. 19).
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only transmission chain that included more than one spa type.
More than one PFGE pattern was seen in another three chains,
nos 2 (t030), 16 (t002) and 25 (t044). In total, 35 of the 39
chains were held together by PFGE and 38 by spa typing
(Table 1). However, allowing closely and possibly related PFGE
patterns within a transmission chain [4] and related spa repeat
patterns, yielded full concordance between epidemiological
data and typing results (Fig. 1).
When considering the 91 single-case isolates, the concor-
dance between epidemiological data and typing results is not
very high, although it is much higher for PFGE than for spa
typing. The number of spa types and PFGE patterns that
were unique (matchless) at the time of identification were
33 and 50, respectively.
In our study, the discriminatory power of PFGE was
higher than that of spa typing (97.3 ± 1.2% vs. 94.9 ± 1.8%).
Numerous studies, based on various collections of MRSA
isolates, have been designed to compare different methods
and their discriminatory power. Grundmann et al. [3] stated
that PFGE was as discriminatory as MLST (97.6% vs.
95.7%). Two studies found spa typing to be as discrimina-
tory as PFGE (97% vs. 96%) [21,30], whereas Stommenger
et al. [20] found spa typing (96.9%) less discriminatory than
PFGE (99.3%) but still better than MLST (93.1%). Even
though the discriminatory power of spa typing was lower
than PFGE in our study, we found the method useful as a
complement to the detailed epidemiological investigations
that were feasible in our low-prevalence setting, character-
ized by few outbreak situations and high numbers of acqui-
sitions abroad. However, we still recommend continued use
of PFGE, for example in reference laboratories, for further
discrimination of isolates with identical spa types whenever
a potential chain of transmission, which can not be disre-
garded based on available epidemiological data, needs to be
investigated.
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